New Results
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Daniel J. Sheward, Changil Kim, Julian Fischbach, Sandra Muschiol, Roy A. Ehling, Niklas K. Björkström, Gunilla B. Karlsson Hedestam, Sai T. Reddy, Jan Albert, Thomas P. Peacock, Ben Murrell
doi: https://doi.org/10.1101/2022.09.16.508299
Daniel J. Sheward
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
2Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Changil Kim
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Julian Fischbach
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Sandra Muschiol
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Roy A. Ehling
3Department of Biosystems Science and Engineering, ETH Zürich
Niklas K. Björkström
4Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Gunilla B. Karlsson Hedestam
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Sai T. Reddy
3Department of Biosystems Science and Engineering, ETH Zürich
Jan Albert
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Thomas P. Peacock
5Department of Infectious Disease, Imperial College London, London, UK
Ben Murrell
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

Article usage
Posted September 19, 2022.
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Daniel J. Sheward, Changil Kim, Julian Fischbach, Sandra Muschiol, Roy A. Ehling, Niklas K. Björkström, Gunilla B. Karlsson Hedestam, Sai T. Reddy, Jan Albert, Thomas P. Peacock, Ben Murrell
bioRxiv 2022.09.16.508299; doi: https://doi.org/10.1101/2022.09.16.508299
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Daniel J. Sheward, Changil Kim, Julian Fischbach, Sandra Muschiol, Roy A. Ehling, Niklas K. Björkström, Gunilla B. Karlsson Hedestam, Sai T. Reddy, Jan Albert, Thomas P. Peacock, Ben Murrell
bioRxiv 2022.09.16.508299; doi: https://doi.org/10.1101/2022.09.16.508299
Subject Area
Subject Areas
- Biochemistry (9599)
- Bioengineering (7092)
- Bioinformatics (24864)
- Biophysics (12615)
- Cancer Biology (9957)
- Cell Biology (14354)
- Clinical Trials (138)
- Developmental Biology (7949)
- Ecology (12107)
- Epidemiology (2067)
- Evolutionary Biology (15989)
- Genetics (10925)
- Genomics (14743)
- Immunology (9869)
- Microbiology (23676)
- Molecular Biology (9485)
- Neuroscience (50871)
- Paleontology (369)
- Pathology (1539)
- Pharmacology and Toxicology (2683)
- Physiology (4015)
- Plant Biology (8657)
- Synthetic Biology (2397)
- Systems Biology (6436)
- Zoology (1346)